Serum Biomarkers for Experimental Acute Spinal Cord Injury: Rapid Elevation of Neuron-specific Enolase and S-100β
- 1 February 2005
- journal article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 56 (2) , 391-397
Abstract
OBJECTIVE:. We evaluated whether serum levels of neuron-specific enolase (NSE) and S-100β protein are biomarkers for traumatic injury in an animal modelKeywords
This publication has 61 references indexed in Scilit:
- Functional and electrophysiological changes after graded traumatic spinal cord injury in adult ratExperimental Neurology, 2005
- Patient Selection for Clinical Trials: The Reliability of the Early Spinal Cord Injury ExaminationJournal of Neurotrauma, 2003
- Spatial and temporal evolution of hemorrhage in the hyperacute phase of experimental spinal cord injury: In vivo magnetic resonance imagingMagnetic Resonance in Medicine, 2000
- Serum S-100 Protein in Acute StrokeStroke, 1998
- The appearance of S-100 protein in serum during and immediately after cardiopulmonary bypass surgery: A possible marker for cerebral injuryJournal of Cardiothoracic and Vascular Anesthesia, 1997
- S-100 Protein: Serum Marker of Focal Brain Damage After Ischemic Territorial MCA InfarctionStroke, 1997
- Serum S-100 Protein, Relationship to Clinical Outcome in Acute StrokeAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1997
- Serum Neuron-Specific Enolase, Carnosinase, and Their Ratio in Acute StrokeStroke, 1996
- Elevated serum levels of S-100 after deep hypothermic arrest correlate with duration of circulatory arrestEuropean Journal of Cardio-Thoracic Surgery, 1996
- Calcification of axons in experimental spinal cord traumaAnnals of Neurology, 1977